Our microarray analysis identified novel candidate differentially methylated regions for IUGR, including those overlapping the promoters of three genes DECR1, LEPR, and ZNF300. These differences were statistically significant when validated by an independent methodology, bisulfite pyrosequencing. The gene discussed is ZNF300; the disease is fetal growth restriction.